DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $707,843 | -21.5% | 55,648 | -13.1% | 0.00% | -50.0% |
| Q2 2023 | $901,416 | +86.1% | 64,021 | +104.2% | 0.00% | +100.0% |
| Q1 2023 | $484,358 | +20.8% | 31,350 | +346.6% | 0.00% | 0.0% |
| Q4 2020 | $401,000 | -67.1% | 7,019 | -70.5% | 0.00% | -50.0% |
| Q3 2020 | $1,219,000 | +3.4% | 23,759 | +20.3% | 0.00% | 0.0% |
| Q2 2020 | $1,179,000 | +13.6% | 19,743 | -21.7% | 0.00% | 0.0% |
| Q1 2020 | $1,038,000 | -12.3% | 25,211 | +32.6% | 0.00% | +100.0% |
| Q4 2019 | $1,183,000 | +447.7% | 19,013 | +84.4% | 0.00% | – |
| Q4 2018 | $216,000 | – | 10,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |